555 related articles for article (PubMed ID: 24292392)
1. Self-renewal as a therapeutic target in human colorectal cancer.
Kreso A; van Galen P; Pedley NM; Lima-Fernandes E; Frelin C; Davis T; Cao L; Baiazitov R; Du W; Sydorenko N; Moon YC; Gibson L; Wang Y; Leung C; Iscove NN; Arrowsmith CH; Szentgyorgyi E; Gallinger S; Dick JE; O'Brien CA
Nat Med; 2014 Jan; 20(1):29-36. PubMed ID: 24292392
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer: targeting self-renewal of cancer stem cells in colorectal cancer-a future treatment option?
Leake I
Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):75. PubMed ID: 24345889
[No Abstract] [Full Text] [Related]
3. Anticancer drugs: Curbing self-renewal of cancer-initiating cells.
Crunkhorn S
Nat Rev Drug Discov; 2014 Feb; 13(2):102. PubMed ID: 24481304
[No Abstract] [Full Text] [Related]
4. Targeting self-renewal, an Achilles' heel of cancer stem cells.
Wicha MS
Nat Med; 2014 Jan; 20(1):14-5. PubMed ID: 24398956
[No Abstract] [Full Text] [Related]
5. Targeting of BMI-1 with PTC-209 inhibits glioblastoma development.
Kong Y; Ai C; Dong F; Xia X; Zhao X; Yang C; Kang C; Zhou Y; Zhao Q; Sun X; Wu X
Cell Cycle; 2018; 17(10):1199-1211. PubMed ID: 29886801
[TBL] [Abstract][Full Text] [Related]
6. A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer.
Wang J; Xing Y; Wang Y; He Y; Wang L; Peng S; Yang L; Xie J; Li X; Qiu W; Yi Z; Liu M
J Exp Clin Cancer Res; 2019 Oct; 38(1):422. PubMed ID: 31640758
[TBL] [Abstract][Full Text] [Related]
7. Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment.
Bolomsky A; Schlangen K; Schreiner W; Zojer N; Ludwig H
J Hematol Oncol; 2016 Mar; 9():17. PubMed ID: 26935956
[TBL] [Abstract][Full Text] [Related]
8. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
[TBL] [Abstract][Full Text] [Related]
9. Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapy.
Nishida Y; Maeda A; Chachad D; Ishizawa J; Qiu YH; Kornblau SM; Kimura S; Andreeff M; Kojima K
Cancer Sci; 2015 Dec; 106(12):1705-13. PubMed ID: 26450753
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.
Srinivasan M; Bharali DJ; Sudha T; Khedr M; Guest I; Sell S; Glinsky GV; Mousa SA
Oncotarget; 2017 Jun; 8(24):38731-38742. PubMed ID: 28418883
[TBL] [Abstract][Full Text] [Related]
11. BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer.
Bansal N; Bartucci M; Yusuff S; Davis S; Flaherty K; Huselid E; Patrizii M; Jones D; Cao L; Sydorenko N; Moon YC; Zhong H; Medina DJ; Kerrigan J; Stein MN; Kim IY; Davis TW; DiPaola RS; Bertino JR; Sabaawy HE
Clin Cancer Res; 2016 Dec; 22(24):6176-6191. PubMed ID: 27307599
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
[TBL] [Abstract][Full Text] [Related]
13. shRNA targeting Bmi1 impedes the self-renewal of cisplatin-enriched stem-like cells in human A549 cells.
Xu Y; Hu YD; Zhou J; Zhang MH; Yuan WW; Luo Y
Oncol Rep; 2012 Aug; 28(2):629-39. PubMed ID: 22664532
[TBL] [Abstract][Full Text] [Related]
14. Tight Junction Protein Claudin-2 Promotes Self-Renewal of Human Colorectal Cancer Stem-like Cells.
Paquet-Fifield S; Koh SL; Cheng L; Beyit LM; Shembrey C; Mølck C; Behrenbruch C; Papin M; Gironella M; Guelfi S; Nasr R; Grillet F; Prudhomme M; Bourgaux JF; Castells A; Pascussi JM; Heriot AG; Puisieux A; Davis MJ; Pannequin J; Hill AF; Sloan EK; Hollande F
Cancer Res; 2018 Jun; 78(11):2925-2938. PubMed ID: 29510994
[TBL] [Abstract][Full Text] [Related]
15. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
16. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells.
Liu X; Wang L; Cui W; Yuan X; Lin L; Cao Q; Wang N; Li Y; Guo W; Zhang X; Wu C; Yang J
Oncotarget; 2016 Sep; 7(36):58516-58530. PubMed ID: 27542268
[TBL] [Abstract][Full Text] [Related]
17. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W
Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
[TBL] [Abstract][Full Text] [Related]
19. The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
Mayr C; Wagner A; Loeffelberger M; Bruckner D; Jakab M; Berr F; Di Fazio P; Ocker M; Neureiter D; Pichler M; Kiesslich T
Oncotarget; 2016 Jan; 7(1):745-58. PubMed ID: 26623561
[TBL] [Abstract][Full Text] [Related]
20. miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1.
Zhang Y; Zhou SY; Yan HZ; Xu DD; Chen HX; Wang XY; Wang X; Liu YT; Zhang L; Wang S; Zhou PJ; Fu WY; Ruan BB; Ma DL; Wang Y; Liu QY; Ren Z; Liu Z; Zhang R; Wang YF
Sci Rep; 2016 Feb; 6():19995. PubMed ID: 26847520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
